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One of the more puzzling features of modern blood coagulation theory is the patho- 
genesis of hemophilia with its mutually exclusive  "procoagulant-deficit" and "anti- 
cephalin-excess"  hypotheses. Briefly, in  the  "procoagulant-defidt"  hypothesis the 
hemophilia gene is  expressed  biochemically  as  inadequate production of the anti- 
hemophilic  factor (AHF), a  coagulant factor required for normal hemostasis.  The 
antihemophilic factor is considered  to be produced in adequate amounts in normal 
animals  by the action of the normal allele(s) at the hemophilia locus (1). This factor 
is thought to be necessary at an early stage in dotting for the normal rapid transfor- 
marion of the proenzyme, prothrombin, into its active form, thrombin (2). 
The  "anticephalin-excess" hypothesis postulates  that  the  bleeding  tendency in 
hemophilia results from excess of a  circulating inhibitor, "anticephalin." This sub- 
stance is believed to be present also in normal blood at a lower titer acting to prevent 
intravascular dotting (3-7). An important corollary of this hypothesis is that there 
is a full complement of coagulant factors in hemophilic blood. 
It is fair to state that the "procoagulant-deficit" hypothesis is the orthodox view. 
It constitutes the basic premise both of conventional transfusion therapy for hemo- 
philiacs  and  the fracrionarion of normal plasma for AHF  (8).  The "anticephalin- 
excess" hypothesis was enunciated in its present form in 1943 (9, 10). It has become 
widely known by the accretion of other types of experiments which appear consistent 
with it (11-17). A complete (at that time) summary of the evidence for this view was 
made in 1951 (7), and more recently a pictorial representation has been published (18). 
Several experiments have been considered  important evidence substantiating the 
anticephalin hypothesis. Four of the more important ones  are: I. The accelerated 
clotting of hemophilic  plasma after contact with asbestos.  II. The existence  of the 
biphasic  dotting curve on dilution of plasma.  III. The increased  speed of prothrom- 
bin utilization in hemophilic  blood on dilution.  IV. The activation by ether of an 
"accelerator," presumed to be AHF, in both normal and hemophilic plasma. 
It appeared to us  that  the difference of concept about hemophilia might 
possibly be resolved by experiments on hemophilic dogs. The original descrip- 
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tions of these animals  (19,20)  emphasized  the  similarity of their malady to 
human hemophilia. The experiments thought to imply deficit of a procoagulant 
in  humans  have  been  duplicated numerous  times  in  these  animals  (19-27), 
and are summarized for brevity in Table I. However, the experiments which 
led to the anticephalin idea have not been attempted previously in dogs. 
This paper describes an  attempt  to duplicate in hemophilic dogs the four 
experiments listed above. The questions for which answers have been sought 
are: (a)  Can results similar to those in the hemophilic human be obtained in 
TABLE I 
Comparison  of Human  and Canine Hemophilia 
Test 
Clotting time 
Bleeding  " 
Prothrombin time 
"  concentration 
"  consumption 
Platelets 
Partial thromboplastin time 
Thromboplastin generation test 
Species  of hemophiliac 
Human 
Prolonged 
Normal 
cc 
Impaired 
Normal 
Prolonged 
Plasma-inactive; serum- 
active 
Sex-linked recessive 
Canine 
Mode of inheritance 
Effect of various types of plasma on defective clotting of hemophilic  plasma in  vitro 
Normal human plasma  Corrective  Corrective 
"  dog  "  "  " 
Hemophi~c human plasma  Not corrective  Not corrective 
"  dog  "  "  "  "  " 
Prolonged 
Normal 
Impaired 
Normal 
Prolonged 
Plasma-inactive;  serum- 
active 
Sex-linked recessive 
the  hemophilic  dog?,  and  (b)  Does  extension  of  the  experiments  affect  the 
previous interpretation? 
Materials  and  Methods 
Blood was obtained from the jugular vein of normal and hemophilic  dogs and from the 
antecubital vein of normal human subjects. The two syringe technique,  in which the first 
syringe of blood is discarded, was employed in all instances.  All blood was collected in sill- 
coned syringes, moistened with saline to prevent ingress of air, and often precooled to 4°C. 
Following Tocantins' technique  (7) the anticoagulant used in many experiments was 38 per 
cent sodium citrate in the ratio of 0.1 ml. of citrate to 9.9 ml. of blood. The citrate was either 
mixed gently with the blood in a centrifuge  tube, or introduced into the collecting syringe 
prior to venipuncture.  In other experiments blood was drawn into 0.112 rr potassium oxalate 
solution in the ratio of 1 ml. oxalate to 9 ml. blood. 
Plasma was prepared from citrated or oxalated blood by centrifugation in an angle centri- 
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Native plasma was obtained from blood collected in chilled siliconed syringes, transferred 
to precooled siliconed tubes,  and  centrifuged rapidly at the above force for 10 minutes at 
CC. After centrifugation, the supernatant  plasma was removed from the packed cells with 
sliiconed pipettes. 
Dilutions of plasma were made in a serial, twofold fashion in siliconed test tubes in which 
the appropriate saline diluent had been placed previously. After careful mixing, the diluted 
plasmas were transferred with siliconed pipettes to glass or siliconed  clotting tubes. 
Cephalin dotting times were performed in many of the experiments. The standard reaction 
mixture consisted of 0.5  ml. of citrated or native plasma, 0A ml. of 1 per cent cephalin and 
(with citrated plasmas) 0.05 ml. of 0.2 ~  CaCI2 (7). The cephalin was prepared by the method 
described by Langdell et al.  (30)  followed by six precipitations with absolute ethanol. The 
order of addition of reagents depended  upon  the purpose  of the experiment.  Usually, the 
plasma was added  to a  tube containing cephalln and  CaCI2. In other experiments,  plasma 
was added  to cephalin,  and  the  CaCI2 introduced  later.  A  stop-watch was started  at  the 
completion of the threefold mixture and stopped when relation occurred. 
Prothrombin content of various samples of plasma was assayed by the two stage method of 
Smith, Warner, and Brinkhous as described by Wagner et al. (28). 
Prothrombin  utilization  rate of blood obtained from hemophilic dogs was determined by 
the method of Buckwalter, Blythe, and Brinkhons as described by Graham eta/. (29). 
The antihemophilic activity (AHF) of plasma samples was determined by the partial throm- 
boplastin technique (30). 
Fibrinogca levels were measured by clotting a 0.2 ml. sample of citrated plasma with 0.02 
ml. of 100 unit per ml. thrombin topical and 0.2  ml. of an equal mixture of 0.02  M CaC12, 
0.017 per cent imidazole buffer at pH 7.25, and 0.9 per cent saline. After 30 minutes, the clot 
was wound out on a  clean glass rod and  thoroughly washed once with 0.9 per cent NaC1, 
twice with acetone, and twice with ether. The rod, with the clot, was transferred to a Nessler 
tube for digestion with a mixture consisting of 2 ml. 10 N H2SO4 (reagent grade) and 0.4 ml. 
of  a  saturated  solution  of  nitrogen-free  Na2SO4. The  nitrogen  content  of  the  clot  was 
determined colorimetrically (31), and expressed as milligrams per cent of fibrinogen. 
Plasma and serum electrolytes were determined by the methods described in the references 
indicated, i. e. sodium and potassium (32), chloride (33), calcium (34), phosphorus (35). 
Total  osmolarity  was  determined  with  the  Fiske  osmometer  (Fiske  Associates,  Inc., 
Boston, Massachusetts)  by the freezing point method. 
Conductidties  of solutions were measured, temperature controlled, with an International 
Instruments conductivity bridge and expressed in mhos. 
Ether  Extraction  of Plasma.--The  normal  and  hemophillc dog  plasmas  were  extracted 
essentially by Johnson's technic (11) as follows. One lot of each type of plasma was defibrinated 
by the addition of an equal volume of purifed citrate-activated thrombin diluted to 20 units 
per ml.; the other lot was extracted without thrombin defibrination. In both instances equal 
volumes of plasma and  anesthetic ethyl ether (u.s.P.)  were mixed in stoppered Erlenmeyer 
flasks and shaken in a mechanical shaker for 30 minutes at room temperature. The mixtures 
were allowed to stand at room temperature in the stoppered flasks for 15 minutes, by which 
time the ether layer had separated. The ether layer was removed by pipetting, and the pro- 
cedure repeated twice more. The extracted plasma samples then were placed in a  vacuum 
dessicator under reduced pressure at room temperature. After 2 hours under these conditions 
the odor of ether in the samples was usually barely detectable. The samples were quickly 
frozen at  -20°C. and  stored overnight, analyses being performed the following day on all 
samples. 
Partial thromboplastin times of various plasmas and mixtures of plasmas were determined 
by the method of Langdell et al.  (24).  The cephalln used was a  0.3  per cent suspension as 
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Thromboploalin generatgon test (36) was performed on normal and hemophilic dog plasmas 
treated in a variety of ways. In all experiments the same 0.03 per cent cephalin suspension 
(30) and the same sample of normal dog serum diluted  1-10 with 0.9 per cent NaCI were 
used. Oxalated plasmas were adsorbed with 100 nag. BaSO4 per ml. It was found empirically 
that 0.012 ~ CaCl2 rather than the usual 0.02 M CaCI2 was optimal for this system. 
EXPERIMENTAL 
I. Effect of Contact witk Asbestos on Hemopkit~ Dog Plasma 
It  has  been  shown  that  contact  between  citrated  plasma  and  asbestos 
markedly shortens the cephalin clotting time of both normal and hemophilic 
human plasma (3, 7, 38, 39). This change has been thought due to adsorption 
of plasma anticephalin by the asbestos. It has been remarked by a proponent 
TABLE II 
Tke Effect of Contact with Asbestos on the Clotting Time of Heraopkillc Dog Plasma 
Hemophilic dog No. 
50-28 
51-02 
52-05 
Before 
$0$. 
360 
330 
360 
Cephslln clotting time 
After 
$0#. 
180 
120 
150 
Citrated  plasma was prepared from hemophilic dog blood obtained from each of three 
hemophilic dogs using siliconed equipment. The blood, citrated  in the ratio of 1:I00 with 
38 per cent sodium citrate, was centrifuged in sillconed tubes at 4°C. for 20 minutes at a 
force of 3200 g. A cephalin dotting time was performed on the resulting plasma before and 
after exposure to asbestos fibers (10 mg./ml, for 1 hour at room temperature). The asbestos 
fibers were removed from the treated plasma by centrifugation at 3200 g before testing. 
of  the  anticephalin  hypothesis  that  since  asbestos  apparently  adsorbs 
anticephalin, it should be possible to treat a hemophiliac by transfusion of his 
own plasma after contact with asbestos (7). This inference provided an excellent 
test of the effect of asbestos on hemophilic plasma. 
The experiment was performed 3  times on different hemophilic dogs with 
uniform results.  The clotting time of hemophilic dog plasma was sharply re- 
duced after exposure to asbestos (Table II). The effect of transfusion of this 
adsorbed  plasma on the hemophilic  defect  is  shown  in  Fig.  1.  Prothrombin 
converted very slowly in the blood obtained from the hemophilic dogs prior 
to  transfusion  (curve  A).  After  transfusion  of  autologous  asbestos-treated 
hemophilic plasma with its shorter clotting time, the prothrombin utilization 
rates were essentially unaltered  (curve B). Two of the same dogs were given 
the  same  quantity  of  untreated  citrated  normal  plasma  at  a  later  time. 
Prothrombin disappearance was greatly accelerated, approaching normal (20), 
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H. The Biphasic Clotting Curve on Dilution of Plasma 
The  biphasic dotting  curve on dilution  of plasma was described in  1943 
(9,  10). This phenomenon can be demonstrated without difficulty with both 
dog and human plasma, normal and hemophilic.  In Fig. 2, the characteristic 
descending  limb  (clotting  time  decreasing  on  dilution)  and  ascending  limb 
(clotting time increasing  after passing through a minimum) are illustrated. In 
the experiment shown,  )lasma and Ca  ++ concentrations were varied by dilution 
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FIo.  l. The asbestos-treated  plasmas with the shortened  clotting times  (Table II) were 
auto-transfused into the respective hemophilic donors at a dose of 2 ml. per kg. body weight. 
Prothrombin utilization rates were determined on the recipient dogs immediately before and 
15 minutes after these transfusions.  Two weeks later untreated normal citrated plasma was 
transfused into two of the same hemophilic dogs at 2 ml. per kg., and similar studies performed 
at the same intervals before and after transfusion. Values plotted are the means of 3, 3, and 
2  experiments respectively, each in duplicate.  The  pretransfusion  prothrombin  utilization 
rates  (curve A)  were obtained  on dogs 50-28,  51-02,  52-05.  Asbestos-adsorbed  sutologous 
plasma was given to 50-28, 51-02, 52-05. Fifteen minutes later the test was repeated (curve 
B). Normal plasma was given 2 weeks later to 51-02 and 52-05, and  15 minutes after trans- 
fusion the prothromhin utilization rates were determined (curve C). 
with 0.85 per cent NaC1. The upper curve was produced by addition of a crude 
cephalin preparation, 0.3 per cent w/% and optimal CaCI~ to citrated dog plasma 
serially diluted with 0.85 per cent NaC1. In the lower curve, the plasma was 
clotted with  a  purified  1 per cent  cephalin  preparation.  The  clotting  times 
were greatly shortened by the stronger cephalin and the biphasic nature of 
the curve tended to become obscured, but the descending  and ascending limbs 
were  still  apparent.  The  acceleration  of  clotting  producing  the  descending 
limb of this type of curve has been interpreted as dissociation of an anticephalin- 
cephalin complex,  the dissociation presumably relieving  a pre-existing inhibi- 
tion of the factors tending to clot. The ascending limb, deceleration of clotting, 
appears clearly to represent dilution of the clotting elements past a  critical 
concentration. 
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became an issue, because the solutions used as anticoagulant and for recalcifica- 
tion  were  highly concentrated.  It  was  noted  first by Tocantins  (39,40)  and 
has  been  our  experience uniformly,  that  the most  markedly biphasic curves 
are produced by highly concentrated citrate and calcium solutions. Obviously 
ionic strength is greater initially in such plasmas than in conventionally citrated 
and  recalcified  plasmas.  It  seemed  possible  that  ionic  strength  might  be 
changing appreciably between dilutions on the descending limb of these curves, 
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FIG. 2. Plasma was prepared from blood citrated in a ratio of 1:100 with 38 per cent so- 
dium citrate. The blood was centrifuged  in siliconed tubes for 1 hour at 3200 g at 4°C. to 
obtain platelet-poor plasma. The upper ~  of the plasma layer was removed and diluted with 
0.85 per cent saline. The plasma was recalcified by adding 0.5 ml. to a test tube containing 
0.1 ml. of cephalin, then adding 0.05 ml. of 0.2 ~t CaCI~. When plasma was diluted with saline 
the CaC12 was correspondingly  diluted with the same saline solution (37). 
and determination of ionic strength in these systems became essential. It was 
found that direct determination of ionic strength in a  complex mixture of salts 
and colloids such as plasma was not possible. We were advised that the best 
approximation would be obtained by a calculation based on electrolyte concen- 
trations and employing the fewest assumptions. 
In the estimations subsequently made, the calcium and citrate molarities were calculated 
exactly for all plasmas from the stability equation (since these molarities are multiplied by 
4 and 9 respectively)  and the following simplifying assumptions made:-- 
1. That the electrolyte concentrations of our dogs were the same as the mean values found 
in the literature (41). (Determinations of Na, K, C1, P, Ca showed that our dogs were normal 
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2.  That  all electrolytes in plasma  except calcium and  citrate were  completely ionized. 
(This assumption is obviously not correct since plasma is not a  dilute solution and gives a 
higher value than the true value. The same assumption,  however, was made in estimating 
the ionic strength of all types of plasma). 
3. That all the calcium of plasma,  bound and free, but none of the magnesium reacted 
with the citrate.  (This simplifies  the calculation and has little effect on the result). 
4. That secondary ionization of phosphate could be neglected. 
5. That the only complex of calcium and citrate which formed was the univalent anion, 
CaCitrate-, formed reversibly from one molecule of Ca  ++ and one molecule of citrate', with 
a  stability constant of 1585 (42, 43). 
It should  be emphasized  that  these assumptions  give values for ionic strength  of both 
native and citrated plasma which are somewhat higher than the true values. However, the 
crucial values are the differences in ionic strength  between types of plasma and  successive 
dilutions of the same plasma, not the exact ionic strength of a specific plasma. 
Using the assumptions  mentioned earlier, and  taking into consideration dilution of the 
inert ions, the increase in sodium and chloride on citration and recalcification, and the cal- 
cium-citrate  equilibrium,  it  was  estimated  that  the  ionic strength  after  recalcification of 
citrated plasma from a dog with a 41 per cent hematocrit reading was 0.2079 when the blood 
was citrated with 38  per cent sodium citrate and  recalcified with 0.2  K  CaClz. The ionic 
strength  of native plasma,  under  the same assumptions,  was 0.1522,  and  that of 0.85  per 
cent NaCI was 0.1454.1 Further calculations verified what had been anticipated intuitively. 
x The actual data on which the ionic strengths were calculated were:-- 
/lg. 
[C03. 
;1. 
IPO,. 
;04. 
.'a. 
,'itrate. 
"aCitrate 
Sum. 
Ion species 
Molarlty 
0.1500 
0.0044 
0.0009 
0.0205 
O. 1060 
0.0014 
0.0010 
0.0026 
Native  >lasma  Recalcitied-citrated  plasma 
mi~¢ t 
0.1500 
0.0044 
0.0036 
0.0205 
0.1060 
0.0056 
0.0040 
0.0104 
Molarlty 
O. 1933 
O. 0039 
0.0008 
0.0183 
O. 1310 
0.0012 
0.0009 
0.0037 
O. 0029 
O. 0168 
0.3045 
0.1522 
miv¢ s 
0.1933 
0.0039 
0.0032 
0.0183 
O. 1310 
0.0048 
O. 0036 
O. 0148 
0.0261 
O. 0168 
0.4158 
0.2079 
It is interesting to note that conductivity measurements and freezing point determina- 
tions on the two plasmas were consistent with the hypothesis that  the recalcified-citrated 
plasma has an ionic strength greater than native plasma:-- 
.'alculated ionic strength, ~. 
.'onductivity, mhos (25°C.) 
)smolarity, milliosmols/kg. HsO. 
Reealcified- 
citra~sma 
0.2079 
0.0129 
396 
Native plasma 
CN) 
O. 1522 
0.0103 
350 
Ratio 
R-C/N 
1.36 
1.25 
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The decrease in ionic strength was greater between successive dilutions of strongly citrated 
plasma than the decrease between successive dilutions of conventionally citrsted plasma or 
nstive plasma. 
Our tentative hypothesis that the biphasic dilution curve is a result of un- 
controlled ionic strength was tested empirically by diluting plasma  in three 
fashions. In one set of experiments an attempt was made to maintain ionic 
strength  constant  on  dilution;  in  another  ionic  strength  was  decreased  or 
increased  very markedly.  Under  the  anticephalin  hypothesis,  the  biphasic 
curves should persist in all instances. If the descending limb of the curve results 
TABLE III 
Cephalin Clotting Times of Native Plasma, Normal and HemopMlic, diluted u,ith 
0.89 per cent NaCl 
CephaIin clotting times 
Plums Concentration  Hernophilic pluma 
Dog 52-16  Dog 55-32 
100 
50 
25 
12.5 
6.25 
3.125 
Normal plasma 
Dos 54--51  Dog 55-05 
$~.  $G$. 
105  125 
109  133 
124  150 
139  190 
335  422 
709  >84O 
$¢G. 
155 
161 
2O2 
218 
364 
> 1080 
$¢4:. 
165 
170 
198 
217 
485 
82O 
Native plasma was prepared from 2 normal and 2 hemophilic dogs by the 2 syringe tech- 
nique using chilled siliconed syringes, centrifuge tubes, pipettes, and clotting tubes. Blood 
was centrifuged at 3200 g for 5 minutes at 4°C. Plasma dilutions were made rapidly by 
serial dilution, and diluted plasma was transferred in 0.5 ml. lots to siliconed tubes con- 
taining 0.1 ml. of 1 per cent cephalin. 
from decreasing ionic strength, dilution should produce the following effects: 
(a)  When  ionic strength  does not  change,  the  clotting  time  should  remain 
essentially constant in the first several dilutions, then lengthen; (b) When ionic 
strength is reduced the clotting time should shorten before increasing; (c) When 
ionic strength is increased, the clotting time should lengthen, the extent de- 
pending on the rate of change in ionic strength. 
In  the  first  set  of  experiments,  an  attempt  was  made  to  maintain 
ionic  strength  constant  during  dilution.  Native  dog  plasma  (without  anti- 
coagulant or additional calcium)  was diluted with 0.89 per cent NaC1, both 
having  ionic strength  calculated  to  be  approximately 0.15.  The results  are 
shown in Table IIL The dilution curves of both normal and hemophilic dog 
plasma were "monophasic" when the plasma was diluted with an "iso-ionic" 
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In the next set of experiments  (Fig. 3) the effects of markedly reducing and 
markedly increasing  ionic  strength  were  compared  on  samples  of  citrated 
plasma. This plasma,  ionic strength calculated to be approximately 0.21, was 
diluted with distilled water or with saline solutions at several concentrations. 
Distilled water exaggerated  the biphasic curve. The usual biphasic curve was 
obtained with 0.85 per cent saline. Saline solutions  of ionic strength greater 
than plasma abolished the biphasic phenomenon,  the curve with 2.09 per cent 
NaC1 rising more rapidly than the one with 1.7 per cent NaC1. 
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FIO. 3. Citrated plasma was prepared and tested as described in Fig. 2. The plasma was 
diluted with three  saline solutions of widely varying ionic strength  and  also with distilled 
water. The clotting time values are the averages of duplicate determinations. 
liT. Effect of Dilution  of ttemopltilic  Blood on Prothrombin Ulilization 
It has been  reported  that  the rate  of prothrombin utilization in human 
hemophilic blood increases on dilution, a fact consistent with the anticephalin 
excess hypothesis (7). In the human experiments  used for adducing this fact, 
prothrombin utilization rates were compared  in undiluted hemophilic  blood 
and the same blood diluted 1:2 with 0.85 per cent saline. The 1:2 dilution is 
ideal for this comparison,  because the minimum clotting time of the biphasic 
dilution curve  of citrated plasma  usually occurs  at  this  dilution, and pro- 
thrombin is still sufficiently concentrated for accurate assays by the two-stage 
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An  experiment,  similar  to  the  human  experiment  (7),  was  performed  on 
undiluted  whole hemophilic dog blood and  the  same blood diluted  1:2 with 
0.85  per cent saline.  The data from four experiments on different hemophilic 
dogs are recorded in Fig. 4. This has been accomplished by plotting the residual 
prothrombin in undiluted blood, at a given incubation time, against the residual 
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Fzo. 4. Undiluted native whole blood and whole blood diluted 1: 2 with 0.85 per cent NaCI 
were obtained from hemophilic dogs with siliconed syringes at the same venipuncture.  The 
diluted  blood was obtained  by half-filling a  siliconed syringe with saline and withdrawing 
blood to capacity.  The blood was mixed evenly by several careful inversions, then trans- 
ferred in 1 ml. quantities  to the clotting tubes. A complete series of both plain glass and sill- 
coned tubes were used in each experiment. At intervals up to 4 hours prothrombin utilization 
was stopped by the addition of 0.15 ml. of 3.2 per cent sodium citrate  to several of the tubes 
of each  type. The citrated  blood was centrifuged,  and citrated  serum  obtained.  Residual 
prothrombin  was determined  by the two-stage method  on the samples from each dog, un- 
diluted  and diluted,  in duplicate,  in both siliconed and plain glass tubes.  Duplicate  values 
were averaged,  and the averages plotted  on the chart. The experiment was repeated  four 
times on different hemophilic dogs. 
prothrombin in the matched 1: 2 dilution from the same dog at the same incuba- 
tion time. This type of analysis permits comparison of all pairs of values with 
a  single test.  The comparison is independent  of the period of incubation,  the 
conversion rate at any time,  the particular dog, or the type of surface in the 
clotting tubes. If there is no difference between the rates in the paired samples, 
all points in Fig. 4  should lie on a  line with slope, m  --- ~.  It can be seen that 
the data approximate this theoretical line rather closely, suggesting that there 
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found that  for either plain glass or siliconed  glass such a  close fit would be 
expected to occur less than once in 10,000 times by chance if the rates were 
different. 
It will be noted in Fig. 4 that some of the prothrombin values of undiluted 
blood are greater than  100 per cent and of diluted blood greater than 50 per 
cent.  This phenomenon was observed in all four experiments usually in the 
30  and  50  minute  samples.  Taken  literally,  it  would  appear  that  the 
prothrombin  concentration  increased  during  the  early period  of the  experi- 
ment. On the other hand, this increase might have been apparent rather than 
real. Conceivably it could have resulted from (a) deterioration of antithrombin, 
(b)  transformation  of prothrombin  from a  less  to more active form  (44),  or 
(c) an incubation mixture for the two-stage prothrombin test not optimal with 
respect to serum accelerators (25). However, from the standpoint of the com- 
parison of prothrombin  disappearance rates in undiluted  and  diluted  blood 
this puzzling  observation appears irrelevant. Both diluted and undiluted blood 
showed  the  same  degree  of  the  same  phenomenon;  i.e.  the  points  with 
coordinates greater than (100,50) failed to deviate from the theoretical line. 
IV. Some Effects of Ether Treatment of Plasma 
It  has  been  observed  that  the  conversion  of  "purified"  prothrombin  to 
thrombin in the presence of calcium,  At-globulin, and platelets is accelerated 
by the addition of ordinary plasma, or of plasma extracted with ether (11-15). 
It has been suggested that  the factor accelerating this  reaction is the anti- 
hemophilic factor (AHF). Hemophilic and normal plasma, after ether extrac- 
tions, have been found to react similarly in this system. The similarity of effects 
with the two types of plasma has been attributed to removal by the ether of 
a  lipide "anticephalin,"  unmasking the antihemophilic factor but not altering 
it.  This interpretation  assumes that  the two plasmas initially contained the 
same quantity of AHF and differed only in a greater concentration of "anti- 
cephalin" in the hemophilic. 
It was decided to determine the AHF activity of ether-treated plasma using 
hemophilic  plasma  as  substrate  rather  than  purified  prothrombin.  Several 
methods were used to test for AHF activity including  an in vitro AHF assay, 
transfusion of treated plasmas to hemophilic  dogs, the partial thromboplastin 
times of various mixtures, and the thromboplastin generation test. 
It can be seen (Table IV) that ether extraction alone,  aside from thrombin, 
removed fibrinogen  from the plasmas.  It also reduced the pre-existing A/IF 
activity of the normal plasma to that of hemophilic,  i.e. both approached zero. 
By contrast,  untreated  normal plasma had  a  striking  effect in a  hemophilic 
plasma substrate as represented by a 89 to 100 per cent AHF titer. The controls 
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prothrombin, while thrombin had a rather marked effect. They also show that 
deterioration  of  the  AHF during  the  extraction  procedure  may have  been 
accomplished solely by the ether, although no test was made of the action of 
thrombin alone. 
The finding that antihemophilic activity was not present in ether-extracted 
plasma  as measured  by in  vitro tests was confirmed by in vivo  experiments. 
Large volumes of normal and hemophilic dog plasma were extracted by the 
same technique. Hemophilic dogs were transfused with these extracted plasmas 
TABLE IV 
Some  Effects  of E~her-Extra*tion and  Defibrination  with  Thrombin  on  the  Fibrinogen, 
AHF and ProthromMn of Normal and Hemophili¢ Dog Plasma 
Test 
Fibrinogen, rag. per cent 
One-stage AHF assay, 
per cent 
Two-stage  prothrombin 
units 
Normal plasma 
Ether extracted, 
28°C  Frozen, 
stored, 
_20oc.  Non-  Deft- 
deft-  brination  !  brination 
306  0  0 
100  <5  <5 
294  236  108 
HemophiHe plasma 
Frozen, 
stored, 
--200C 
236 
<5 
288 
Ether-extracted, 
28°C. 
Non-  deft-  Deli- 
brinafion brinstion 
0  0 
<5  <5 
221  129 
Control plasma 
(28°C., 5 hrs. 
not defibrinated) 
Normal  Hemo-  phillc 
89  <5 
240  246 
Normal and hemophilic plasmas were prepared by drawing 9 volumes of normal and 
hemophilic dog blood, separately, into syringes containing 1 volume of 0.112 M  potassium 
oxalate. The blood samples were centrifuged at 3200 g for 30 minutes at 4°C. The super- 
natant  plasmas were pipetted and a sample frozen and stored at  --20°C. for  subsequent 
analysis. The remaining plasma of each type was divided into three lots. One lot was de- 
fibrinated and ether-treated, the second was merely ether-treated, and the third was stop- 
pered and allowed to stand on the bench in a glass container during the course of the experi- 
ment (5 hours). 
at a standard dose of 2 ml. per kg. body weight. Later the same dogs were given 
transfusions  of untreated  normal  plasma  at  the same  dosage.  The effects of 
both types of plasma were measured by prothrombin utilization rates on the 
animals. As usual, untreated normal plasma had a striking effect in accelerating 
prothrombin conversion in the hemophilic dog (as in curve C of Fig. 1).  Con- 
sistent  with  the  in  vitro  experiments,  the  ether-extracted  plasma  from  both 
genotypes had the same negligible effect as the asbestos-adsorbed hemophilic 
plasma of curve B, Fig.  1. 
The conclusion from the preceding experiments, that ether-extracted plasma 
lacked  antihemophilic  activity,  appeared  inconsistent  with  the  repeated 
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"purified" prothrombin.  Another test  system was  devised  with  a  different 
ratio of treated plasma to test substrate. The effect of ether-extracted normal 
and hemophilic dog plasma on an equal volume of untreated hemophilic plasma 
was studied by the partial thromboplastin time (Table V). It can be seen (cf. 
lines 1, 3, 5, 7) that clot-promoting activity was "generated" in both types of 
plasma by the ether treatment. It exceeded in fact the accelerating  effect of 
untreated but BaSO4-adsorbed normal plasma (line 4). However,  as shown in 
lines 6 and 8, the activity "generated" was removed  by adsorbing  the ether- 
extracted plasmas with BaSO4. In view of the fact that the AHF is not adsorbed 
TABLE V 
Partial  Thromboplastin  Times of Hemophili¢ Plasma When Mixed with Ether-Extracted 
and BaSO4-Adsorbed Plasmas, Normal and ltemophilic* 
Hmo  o 
Line  I~hilic 
No.  plasma 
0.10 
0.05 
0.05 
0.05 
0.05 
0.05 
0.05 
Un- 
treated 
O. 10 
0.05 
Normal plasma 
BaSO4- 
adsorbed 
0.05 
I Defibrinated 
Defibrinated, rether-treated 
ether-treated  BaSO4- 
adsorbed 
0.05 
0.05 
Hemophillc plasma 
Defibrinated 
Defibdnated, ether-treated 
ether-treated  BsSO4- 
adsorbed 
0.05 
0.05 
Partial 
thrombo- 
plastin 
time 
91 
41 
53 
39 
79 
40 
85 
* Plasmas were prepared as described in detail in the methods section and the footnote 
to Table IV. 
by BaSO4 (22), this experiment seems to imply that the activity "generated" 
was not AHF. 
The  activation by ether  of  a  clotting factor  with  effects  in  the  partial 
thromboplastin time was examined also in the thromboplastin generation test 
(Fig. 5). The plasmas were prepared exactly as in the previous experiments and 
used  as  the  source  of  plasma  for  this  test  with  and  without  adsorption 
by BaSO4. In all generation tests except curve A, the normal control, the plasma 
under study was mixed with an equal part of fresh, BaSO4-adsorbed hemophilic 
dog plasma.  This step was introduced because an adequate supply of factor V 
has been shown to be necessary  for a normal generation test (45, 46). It can 
be seen that ether-extracted normal plasma was active in this system, but some- 
what less active than untreated normal plasma (cf.  curves  B and D). When 
the extracted  normal plasma was  adsorbed  with BaSO4, it lost most of its 
generative activity, becoming quasihemophilic  (cf.  curves  B, D, and F  with 286  PATHOOENESIS O~  HEMOPHILIA 
C). Similarly,  ether extraction activated a  component of hemophilic plasma 
which showed some activity in the generation test (of. curves C and E). Again, 
however, it can be seen that the activity "generated" was largely adsorbed by 
BaS04 (of. curves C, E, and G). 
36' 
34-~ 
32- 
30-I 
28- 
¢n 26- 
c~ 
z  24- 
o 
022- 
u~ 20- 
jiB- 
~  I0  o 
8- 
6- 
4- 
2" 
,~o  _.  ..A 
,  ,,  ,, 
o  3'o'  sb'  ~0"  .~o" 
INCUBATION  TIME, SECONDS 
Fro. 5.  Thromboplastin G~eration  Test.--All tests were done using the same normal dog 
serum, diluted 1-10, and the same 0.03 per cent cephalin suspension. Plasma mixtures con- 
sisted of equal parts each type as recorded  below. The plasmas, diluted 1-4, were as follows: 
curve A  (normal, BaSO4-adsorbed),  curve B  (hemophflic, BaSO4-adsorbed  +  normal, BaSO4- 
adsorbed), curve C  (hemophilic,  BaSO4-adsorbed),  curve D  (hemophillc,  BaSO4-adsorbed  q- 
normal, ether-treated), c~rve E  (hemophilic,  BaSO4-adsorbed  -[- hemophilic, ether-treated), 
curve  F  (hemophilic,  BaSO4-adsorbed  -b  normal, ether-treated,  BaSO4-adsorbed),  curve G 
(hemophilic,  BaSO4-adsorbed  -b  hemophilic, ether-treated,  BaSO4-adsorbed).  The normal 
mixture (curve A) when fully activated gave the following clotting times on dilution with 
saline: undiluted (100 per cent)  =  7.4 seconds; 1:2 dilution (50 per cent)  =  8.4 seconds; 
1:4 dilution (25 per cent)  --  14.8 seconds;  1:8 dilution (12.5 per cent)  =  29.6 seconds. 
DISCUSSION 
Great care was taken  in  these experiments  to duplicate the conditions of 
the  original  human  experiments,  because the plasma-clotting  mechanism  is 
known to be labile and subject to systematic error. It should be emphasized 
that the original human experiments have been significantly  extended in these 
dog experiments,  particularly  by transfusing  variously treated  plasmas into 
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It is important to note that contact with asbestos  greatly reduced the in 
vitro clotting time of hemophilic dog plasma but that this plasma was inactive 
when transfused. This dichotomy suggests that the effect of asbestos has been 
something other than removal of an inhibitor or an "unmasking"  of AHF. 
Perhaps an accelerator  is activated by asbestos, such as the BaSO4-adsorbable 
serum accelerator(s)  known to shorten markedly the clotting time of hemo- 
philic blood in vitro without significantly affecting the prothrombin utilization 
rate (25). 
In considering the experiments  on the biphasic  clotting curve,  it should be 
pointed out that there are serious  theoretical objections  to a  calculation of 
plasma ionic strength from electrolyte concentrations.  Plasma is too concen- 
trated to follow dilute solution theory and contains a variety of colloids. How- 
ever, if this important variable is considered seriously, there is no better alterna- 
tive  at  present.  There  are  also  serious  objections  to  conductometric 
determinations of plasma ionic strength. Not the least of these objections  is 
the theoretical one. Conductivity  measures the speed of migration of ions while 
ionic strength is a measure of the "ion atmosphere," a function of both concen- 
tration and squared charge. The fact that ionic strength is commonly estimated 
conductometrically in the laboratory on the monovalent ions  of saline  (by 
determining  conductivity,  obtaining  concentration  by  comparison  with 
standard solutions,  then assuming  complete  ionization)  by no means implies 
that this is an exact method or can be applied to plasma. 
In prospect it was anticipated that the trivalent citrate and bivalent calcium 
ions would make heavy contributions to the calculated ionic strength of citrated 
plasma.  Actually they were of secondary importance in the calculations,  since 
the stability constant of calcium citrate is fairly high, and the two ions were 
present in almost equimolar proportions.  Roughly 60 per cent of the increase 
in ionic strength of citrated over native plasma was  contributed by the  ex- 
cess sodium and chloride acquired on citration and recalcification. 
The  experiments  on  the  biphasic  clotting curve  are  consistent with  our 
hypothesis that the biphasic  curve results from uncontrolled ionic strength. 
They show that experimental conditions  in which ionic strength may reason- 
ably be expected to remain constant or increase abolish the phenomenon,  and 
that conditions which may reasonably be expected to decrease ionic strength 
more  markedly than  0.85 per  cent  saline  (distilled  water)  exaggerate  the 
phenomenon.  This does not prove that variable ionic strength is the cause of 
the biphasic  curve. However,  it appears that variation in this parameter is at 
least  as likely an  explanation as  dissociation  of a  hypothetical accelerator- 
inhibitor complex. 
If the  biphasic  phenomenon results from decreasing  ionic  strength,  why 
does this decrease  speed clotting? Lovelock and Porterfield  (47) have shown 
that the ionic strength of plasma (4-0.15)  is not optimal for clotting. Their 
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rapid at an ionic strength of around 0.03 to 0.05 and that there is a direct relation- 
ship between ionic  strength  and  clotting time over a  wide range above this 
point. Thus, when plasma is diluted with a "hypo-ionic" solution, ionic strength 
decreases toward  the  optimal.  Furthermore,  the  degree of  "sag"  in  such  a 
dilution curve should be greater with citrated than native plasma when diluted 
with  the  same "hypo-ionic"  diluent.  The  change  in ionic strength  between 
successive dilutions clearly will be greater in the citrated plasma with its ini- 
tially higher ionic strength.  The British workers have suggested that plasma 
ionic strength  is non-optimal with regard to clotting, because the heavy ion 
atmosphere increases the charge of the colloids. The increase in charge probably 
impairs  colloidal  interactions,  perhaps  by repulsion.  As the ion atmosphere 
decreases on dilution, repulsion diminishes,  the probability of colloidal collision 
increases,  and the clotting reactions proceed more rapidly. 
The experiments on the rate of prothrombin utilization  during  clotting of 
diluted and undiluted hemophilic blood appear conclusive.  The data exclude 
with  high  probability  the  notion  that  the  rate  of  prothrombin  utilization 
increases on dilution.  It  should be emphasized  that  the  canine  experiments 
were performed on whole blood without anticoagulation  and that very little 
alteration of ionic  strength  occurred  on  dilution,  a  situation  which,  as has 
already been pointed out, abolishes the biphasic curve. 
The removal of antihemophilic activity by ether extraction of normal dog 
plasma  at  room temperature  is not surprising.  Ether  is known to denature 
protein under this condition, and the antihemophilic factor is one of the more 
labile-clotting factors (48). There is no doubt from our experiments that ether 
removes AHF from normal plasma, if AHF is defined as that activity of normal 
plasma, not adsorbed by BaSO,, which accelerates the delayed clotting and pro- 
tkrombin utilization of hemophilic  blood and plasma in the presence of platdets 
and calcium ions in vitro, and corrects the hemostatic defect when transfused  to a 
hemophiliac.  It  is  difficult  from  the  literature  to  ascertain  why  it  had 
been thought  that  ether-extracted  plasma  contained  AHF,  as  this  type of 
plasma appears not to have been assayed previously in a  specific manner.  It 
is of interest, however, that we also observed something in the ether-extracted 
plasma  of both genotypes which accelerated clotting and  was active in the 
thromboplastin generation test. The fact that this activity could be adsorbed 
with BaS04 appears to exclude AHF as a possibility. 
As a result of these experiments in the dog, it is unnecessary to elaborate an 
"anticephalin"  hypothesis to explain the pathogenesis of canine hemophilia. 
This raises  the question whether canine and human hemophilia are different 
diseases or whether the "anticephalin"  hypothesis is also irrelevant in human 
hemophilia.  A categorical answer cannot be given to this question at present, 
because many of the experiments performed in the dog are dangerous and have 
not been performed in the human. However, it appears that the "anticephalin" 
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appear identical (See Table I). Until the two diseases are shown to be different, 
or incontrovertible evidence supporting  the  "anticephalin" idea is  brought 
forward, it  is  logical  to  conclude that  the "anticephalin" hypothesis is  not 
applicable in either species. 
su~a~Y  ~  CONCLUSIONS 
It has been possible  to duplicate in the hemophilic dog four of the major 
experiments which have suggested in humans an  "anticephalin" hypothesis 
for the pathogenesis of hemophilia. The experiments in  the dog have been 
considerably extended, as compared with the human experiments, by a variety 
of techniques. 
I.  Asbestos  was  placed in  contact with hemophilic dog plasma,  and  the 
clotting time became shorter. When transfused, this plasma had no effect on 
the defective prothrombin utilization of hemophilic dogs,  in contrast to un- 
treated normal plasma. 
II. The ionic strength of native dog plasma and dog plasma  citrated (38 
per cent sodium citrate) then recalcified  (0.2 M CaC12) were calculated. The 
ionic strength of the native plasma was approximately 0.15 while that of the 
citrated plasma was approximately 0.21. 
Conductivity and freezing point determinations on the plasmas described 
above were consistent with the idea that the ionic  strength of the citrated 
plasma was significantly higher. 
The biphasic dilution curve, to which much significance has been attached 
in arriving at the "anticephalin" hypothesis, can be produced readily in the 
dog. 
Diluting  dog  plasma  with  'qso-ionic"  or  "hyper-ionic"  NaCI  solution 
abolished  the biphasic phenomenon. Dilution with distilled  water exaggerated 
the biphasic curve. These experiments suggest  that  the biphasic  curve is an 
artifact of uncontrolled ionic strength. 
IIL  The prothrombin utilization rates of undiluted whole hemophilic dog 
blood and hemophilic dog blood diluted 1: 2 with 0.85 per cent NaC1 were found 
to be the same. 
IV.  Ether extraction of both normal and hemophilic dog plasma removed 
fibrinogen and reduced somewhat the concentration of prothrombin. In treated 
normal plasma AHF was reduced to the level of untreated hemophilic plasma, 
thus producing a quasi-hemophilic  plasma. 
Defibrination and ether extraction of both normal and hemophilic dog plasma 
"generated" clotting activity which shortened the clotting time of hemophilic 
plasma and was active in the thromboplastin generation test. 
The activity "generated" by defibrination and ether extraction of dog plasma 
was adsorbed by a BaSO4 suspension and shown, therefore, not to be the anti- 
hemophilic factor (AHF). 
Transfusion of ether-extracted normal or hemophillc dog plasma into hemo- 290  PATHOGENESIS  OF  HEMOPHILIA 
philic dogs had no effect on the prothrombin utilization rate, unlike untreated 
normal plasma which had a marked effect. 
Thus,  four  of  the  main  lines  of  evidence  supporting  the  "anticephalin" 
hypothesis were duplicated in the dog. However, by extending the experiments 
it was found that all were explainable on bases  other than the presence  of 
"anticephalin." Such an hypothesis is not necessary, therefore, to explain the 
pathogenesis of canine hemophilia. The apparent identity of hemophilia in the 
two species suggests that the hypothesis is also not applicable to humans. 
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